Overview
Matthew Austin is a Hematologist Oncology specialist and a Hematologist in Westerly, Rhode Island. Dr. Austin is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are MAGIC Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, IgG4-Related Disease, and Light Chain Deposition Disease (LCDD).
His clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Renal Cell Carcinoma (RCC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
25 Wells St, Westerly, RI 02891
365 Montauk Ave, Rm 2609, New London, CT 06320
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Toni Choueiri is an Oncologist in Milford, Massachusetts. Dr. Choueiri is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Yale University
Mario Sznol is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Sznol has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes.
Yale University
Harriet Kluger is a Hematologist and an Oncologist in New Haven, Connecticut. Dr. Kluger is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Austin isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bladder CancerDr. Austin isExperienced. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Austin isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Austin isExperienced. Learn about Clear Cell Sarcoma.
- EGFR Positive Lung CancerDr. Austin isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerDr. Austin isExperienced. Learn about Familial Prostate Cancer.